Skip to content
Business

Meta Raises $25bn in a Share Sale to Fund AI, With Nvidia and AMD Buying In

Meta sold $25bn of stock at $625 a share plus $12.5bn of convertible preferred to fund AI spending, with Nvidia and AMD committing $4bn. The shares closed at $620.19, below the offer price.

An aerial view of Meta's Los Lunas data center campus in New Mexico, with its long white buildings beside rows of solar panels in the desert.
Photo: Meta

Meta shares closed at $620.19 on Tuesday, 3.5% below Friday's close and under the $625 price of the $25bn share sale the company priced on Monday to help pay for its AI build-out. Nvidia committed $3bn and AMD $1bn to the offering, which comes alongside a $12.5bn sale of mandatory convertible preferred stock.

How the deal is built

The common stock sale was increased to $25bn from the $22.5bn first planned and priced at $625 a share, 2.7% below Friday's close of $642.62.

It is structured through forward sale agreements with Morgan Stanley and Goldman Sachs, initially covering 40 million shares. Meta expects about $24.9bn of net proceeds, or $28.7bn if the banks use a 30-day option to buy $3.75bn more, and settlement can come as late as 19 November 2027.

Meta's capital raise

  • $25bn common stock, priced at $625 a share
  • $12.5bn mandatory convertible preferred, 6.50% dividend
  • $4bn committed by Nvidia and AMD

The second leg is 250 million depositary shares at $50 each, representing mandatory convertible preferred stock that pays a 6.50% annual dividend. They convert into Meta shares around 15 August 2029, at a rate that depends on the share price at the time. Both deals are due to close on Thursday, 29 October. Meta also plans to sell about $60bn of Class C stock on the market over time, a programme it does not expect to start before the first quarter of 2027 and has not yet signed any agreement for.

A technician on a lift works on power and fibre equipment inside Meta's data center in Temple, Texas.
A technician on a lift works on power and fibre equipment inside Meta's data center in Temple, Texas. Photo: Meta

Chipmakers buy into a customer

Nvidia said it will invest $3bn in the offering as it expands its work with Meta on Muse, Meta's family of AI models. Meta in turn plans to expand its use of Nvidia's Vera Rubin platform, Vera processors, Spectrum-X networking and BlueField-4 chips.

AMD followed on Tuesday with a $1bn commitment. It said its first Helios rack-scale systems are installed and being tested at Meta, and that Meta will deploy a custom Instinct GPU. AMD chief executive Lisa Su said the companies were "taking that partnership to a new scale".

When it launched the sale, Meta said Nvidia, AMD and Broadcom had indicated interest in buying up to $5bn of its shares between them, and stressed that these indications were not binding.

Why Meta needs the money

The raise follows third-quarter results that showed how fast spending is outrunning cash flow. Revenue rose 26% to $64.6bn, ahead of forecasts, but capital spending reached $34.9bn in the quarter, against $19.4bn a year earlier, and free cash flow turned negative at minus $2.1bn, the first negative quarter since 2012, investingLive reported.

Meta lifted the bottom of its 2026 capital spending range to $135bn-$145bn from $130bn and said its future spending commitments had reached about $825bn. The shares fell 6.98% on 22 October, the day after the results, and lost 9.4% that week.

Dilution and the new Class C shares

The results also brought plans for a nonvoting Class C stock, to be handed to all shareholders as a dividend with effect from 19 January 2027. It is also the class Meta plans to use for the $60bn of market sales, which points to further dilution for existing holders. The preferred shares and the forward agreements may later refer to Class C shares instead of the voting Class A stock.

Tuesday's close leaves Meta 17.5% below its close of $751.66 on 25 September.

What investors watch now

The next markers are the closing of both offerings on Thursday and any use of the banks' options to buy more stock. Further out, investors will watch how much Meta sells through later share sales, the distribution of the Class C stock in January, and whether capital spending starts to earn a return in revenue before the cash runs short again.

Sources

Related stories

Business

Nvidia's Jensen Huang Resigns as CEO; CFO Colette Kress Takes Over for Now

Jensen Huang resigned as Nvidia's CEO and director with immediate effect, and CFO Colette Kress became interim CEO, less than a day after a report that the board was preparing to…

Markets

Meta Shares Drop as AI Spending Pushes Cash Flow Negative for the First Time Since 2012

Meta shares traded about 3% lower before the New York open after third-quarter capital spending reached $34.9bn and free cash flow turned negative, overshadowing a 26% rise in…

Markets

AMD Whipsaws: A 17% Plunge After Record Results, Then a 19% Weekly Rebound

AMD rose 18.93% to $534.06 in the week to 13 November, more than recovering a 17.26% one-day fall on 5 November that hit chip stocks after the US midterms, days after record…

Markets

AI Chip Rout Drags the Nasdaq Into Correction, Wiping Out the Post-Election Rally

The Nasdaq fell 5.52 percent on Thursday, its worst day since April 2025, as chipmakers collapsed and the largest US tech groups lost about $900 billion in value.

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…